XINJIANG BAI HUA CUN PHARMA TECH CO.,LTD

Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd

600721

CNE000000KQ1

Biotechnology & Medical Research

End-of-day quote Shanghai S.E. Other stock markets 03:30:00 17/07/2024 am IST			5-day change	1st Jan Change
5.9 ^CNY	+0.85%		+11.53%	-23.77%

25/04	Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
25/04	Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Xinjiang Baihuacun Co., Ltd. Approves the Proposal of Changing Registered Address

January 29, 2019

Xinjiang Baihuacun Co., Ltd. approved the proposal of changing registered address, at its 7th Directorate meeting held on January 29, 2019.

Latest news about Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd

Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04	CI
Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	25/04	CI
Nanjing Huanglong Biotechnology Co., Ltd. announced that it expects to receive CNY 30 million in funding from Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd	24/04	CI
Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	10/23/10	CI
Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	30/23/30	CI
Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	25/23/25	CI
Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	11/23/11	CI
Bai Hua Cun Pharma Tech Unit Raises Capital by 90 Million Yuan	26/22/26	MT
Nanjing Huanglong Biotechnology Co., Ltd. announced that it expects to receive CNY 90 million in funding from Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd	23/22/23	CI
Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	23/22/23	CI
Xinjiang Baihuacun Co., Ltd.(SHSE:600721) added to Shanghai Stock Exchange Composite Index	13/22/13	CI
Xinjiang Baihuacun Co., Ltd.(SHSE:600721) added to Shanghai Stock Exchange A Share Index	13/22/13	CI
Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022	27/22/27	CI
Xinjiang Baihuacun Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	29/22/29	CI
Xinjiang Baihuacun Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	26/21/26	CI
Jiangsu Leeway Biological Technology Co., Ltd. announced that it expects to receive CNY 45 million in funding from Xinjiang Baihuacun Co., Ltd.	17/21/17	CI
Xinjiang Baihuacun Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	17/21/17	CI
Xinjiang Baihuacun Co., Ltd. announced that it expects to receive CNY 338.746321 million in funding from Xinjiang Hualing International Medical Industry Development Co., Ltd	28/21/28	CI
Xinjiang Baihuacun Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	21/21/21	CI
Xinjiang Baihuacun Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	31/21/31	CI
Xinjiang Baihuacun Co., Ltd. cancelled the transaction announced on June 8, 2020	05/21/05	CI
Xinjiang Baihuacun Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020	22/20/22	CI
Xinjiang Baihuacun Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020	19/20/19	CI
Xinjiang Baihuacun Co., Ltd. Provides Earnings Guidance for the First Half of 2020	20/20/20	CI
Xinjiang Baihuacun Co., Ltd. announced that it expects to receive CNY 429.904 million in funding from Xinjiang Hualing International Medical Industry Development Co., Ltd	08/20/08	CI

Chart Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd

Duration

Period

Chart Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd

More charts

Xinjiang Bai Hua Cun Pharma Tech Co Ltd is a China-based company principally engaged in pharmaceutical services. The Company's main business is the research and development, registration and application of small molecule chemicals and the development of peptide drugs. The Company is engaged in the early discovery and screening of new drugs, drug clinical trials, biological sample analysis, medicine testing services, active pharmaceutical ingredient (API) and intermediate supply. The Company is also engaged in leasing and property services. The Company mainly conducts business within the domestic market.

Sector

Biotechnology & Medical Research

Calendar

21/08/2024 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

	1st Jan change	Capi.
XINJIANG BAI HUA CUN PHARMA TECH CO.,LTD	-23.77%	31Cr
VERTEX PHARMACEUTICALS INCORPORATED	+20.03%	13TCr
REGENERON PHARMACEUTICALS, INC.	+23.61%	12TCr
ARGENX SE	+23.26%	2.79TCr
BIONTECH SE	-18.07%	2.1TCr
GENMAB A/S	-15.13%	1.69TCr
BEIGENE, LTD.	-14.81%	1.62TCr
NEUROCRINE BIOSCIENCES, INC.	+9.78%	1.48TCr
WUXI APPTEC CO., LTD.	-46.10%	1.48TCr
SAREPTA THERAPEUTICS, INC.	+52.34%	1.41TCr

Bio Therapeutic Drugs

Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd

Equities

600721

CNE000000KQ1

Biotechnology & Medical Research

Xinjiang Baihuacun Co., Ltd. Approves the Proposal of Changing Registered Address

Latest news about Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd

Chart Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd

Company Profile

Income Statement Evolution

Annual profits - Rate of surprise

Sector Bio Therapeutic Drugs